Related Experiment Video
Updated: May 14, 2026
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Bioinformatics, non-coding RNAs and its possible application in personalized medicine
1Swiss Institute of Bioinformatics, Lausanne, Switzerland. simona.rossi@isb-sib.ch
Advances in Experimental Medicine and Biology
|February 5, 2013
Summary
MicroRNAs (miRNAs) are key non-coding RNAs regulating gene expression, especially in cancer. This review covers 10 years of miRNA research, focusing on identification, data methods, and clinical applications.
Area of Science:
- Molecular Biology
- Bioinformatics
- Genomics
Background:
- Non-coding RNAs, particularly microRNAs (miRNAs), play crucial roles in human biology and gene regulation.
- The transcriptional regulation of miRNAs remains incompletely understood.
- miRNAs are implicated in cancer development and progression, necessitating interdisciplinary research.
Purpose of the Study:
- To review major findings in microRNA research over the past decade.
- To highlight advancements in miRNA identification and prediction techniques.
- To discuss data generation, manipulation methods, and clinical applications of miRNAs.
Main Methods:
- Bioinformatics approaches for data analysis and interpretation.
- Experimental validation of bioinformatic findings.
- Analysis of Next Generation Sequencer data.
- Review of scientific literature from the last 10 years.
Main Results:
- Significant progress in identifying and predicting microRNA functions.
- Development of sophisticated data generation and manipulation techniques.
- Growing evidence for the clinical utility of miRNAs in cancer diagnosis and treatment.
Conclusions:
- MicroRNA research has advanced significantly, driven by bioinformatics and experimental validation.
- Understanding miRNA regulation is crucial for unraveling their role in diseases like cancer.
- MicroRNAs hold promise for future clinical applications in oncology.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
03:21RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...